PRGO News and Press, Perrigo Company plc From 02/19/19

BOSTON, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP ( www.blockesq.com ), a securities litigation firm representing investors nationwide, reminds investors of the important deadlines listed below. If you have purchased or otherwise acquired any of the securities listed below...

The U.S. Supreme Court has rejected the state of Maryland's appeal of an appeals court ruling that struck down its anti-price gouging law citing the illegality of state-level regulation of interstate commerce. More news on: Health Care Select Sect SPDR ETF, iShares Nasdaq Biotechnology E...

Introduction - Teva ( TEVA ) versus branded biotechs TEVA reported Q4 and full-year numbers last week, and the stock sank sharply, with its ADS closing at $17.98 Friday. Using the 1.10 B fully diluted shares the company guided for the present period on the c onference call , that puts its ...

Perrigo ( PRGO ) has a long way to bounce before recovering from a loss of more than 45% from yearly highs. Year-to-date the stock is up 26%, helped by its presentation at the JPMorgan Healthcare conference. But the stock’s valuation is not compelling, its dividend yield is mediocre...

Those of you who follow this series of articles know that I track the dividend increases of a variety of long-term dividend growth companies. Back at the end of January, I provided predictions for 9 dividend growth companies that have historically announced annual payout increases in the first...

In a statement , FDA commissioner Scott Gottlieb, M.D. announces a new pathway for accelerated view of marketing applications from generic drugmakers for off-patent branded medicines facing no generic competition, a situation characterizing "hundreds" of such drugs that serve small patient ...

DUBLIN , Feb. 14, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality, Affordable Self-care Products™" , today announced that its Board of Directors declared a quarterly dividend of $0.19 per share, payable on Marc...

2018 was a horrible year for Perrigo ( PRGO ) and its shareholders. Profit-warning after profit-warning and at the end, as icing on the cake, the heavy tax claim in Ireland. In 2018, Perrigo had three CEOs. It decided to sell or spin off its generics business, but the outlook for this business...

DUBLIN , Feb. 13, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality, Affordable Self-care Products™" , today announced that it has settled its Hatch-Waxman litigation relating to its first-to-file Abbreviated New Drug Applicati...

DUBLIN , Feb. 13, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality, Affordable Self-care Products™", today announced that it will release its fourth quarter and calendar year 2018 financial results on Wednesday, February 27, 2...